Jackson Creek Investment Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Jackson Creek Investment Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,065	Closed	-$451K	–	375
2025 Q4	$451K	Buy	+9,065	New	+$441K	0.13%	217
2023 Q3	–	Sell	-31,118	Closed	-$935K	–	357
2023 Q2	$935K	Buy	31,118 +1,827	+6%	+$63.9K	0.37%	122
2023 Q1	$1.06M	Sell	29,291 -13	-0%	-$500	0.45%	42
2022 Q4	$1.04M	Sell	29,304 -870	-3%	-$30.2K	0.46%	29
2022 Q3	$1.02M	Buy	+30,174	New	+$982K	0.48%	33
2022 Q1	–	Sell	-34,133	Closed	-$995K	–	351
2021 Q4	$995K	Buy	+34,133	New	+$1.04M	0.36%	154
2021 Q1	–	Sell	-45,119	Closed	-$1.14M	–	370
2020 Q4	$1.14M	Buy	+45,119	New	+$971K	0.44%	56

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jackson Creek Investment Advisors's SUPN Position: Q1 2026 in Review

Jackson Creek Investment Advisors sold out of Supernus Pharmaceuticals (SUPN) in Q1 2026, closing a stake of 9,065 shares — an estimated $451K sold.

Jackson Creek Investment Advisors first reported a position in SUPN in Q4 2020 and held it in 7 quarters. The position peaked at $1.14M in Q4 2020. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

Jackson Creek Investment Advisors reported no remaining Supernus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Jackson Creek Investment Advisors sold 9,065 Supernus Pharmaceuticals shares in Q1 2026, an estimated $451K.
Jackson Creek Investment Advisors first reported a position in Supernus Pharmaceuticals in Q4 2020 and held it in 7 quarters.
Jackson Creek Investment Advisors's Supernus Pharmaceuticals position peaked at $1.14M in Q4 2020.
327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2026, filed 5 May 2026.